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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYTIF1b is a transcriptional corepressor that recruits repressive chromatinmodifiers to target genes. Its biological function and physiological
targets in somatic stem cells remain largely unknown. Here, we show that TIF1b is essential for the maintenance of hematopoietic stem
cells (HSCs). Deletion of Tif1b in mice induced active cycling and apoptosis of HSCs and promoted egression of HSCs from the bone
marrow, leading to rapid depletion of HSCs. Strikingly, Tif1b-deficient HSCs showed a strong trend of ectopic expression of nonhemato-
poietic genes. Levels of heterochromatin protein 1 (HP1a, b and g) proteins, which form a complexwith TIF1b, were significantly reduced
in the absence of TIF1b and depletion of HP1 recapitulated a part of the phenotypes of Tif1b-deficient HSCs. These results demonstrate
that the TIF1b-HP1 system functions as a critical repressive machinery that targets genes not normally activated in the hematopoietic
compartment, thereby maintaining the transcriptional signature specific to HSCs.INTRODUCTION
During hematopoiesis, hematopoietic stem cells (HSCs)
activate specific sets of genes and silence others. Transcrip-
tion factors fulfill an obvious role in this process. At the
same time, chromatin modifiers regulate the accessibility
of transcription factors to cis elements by establishing re-
gions of chromatin that are either permissive or repressive
to transcription. These epigenetic transcriptional regula-
tions are crucial for the maintenance of multipotency in
stem cells (Sauvageau and Sauvageau, 2010; Sashida and
Iwama, 2012). Polycomb group (PcG) proteins, which
establish a reversible silencing state through repressive
histone modifications, maintain multipotency of HSCs
by keeping hematopoietic developmental regulator genes
poised for activation via bivalent histone domains (Oguro
et al., 2010). However, the mechanisms by which non-
hematopoietic genes, which should never be activated
in the hematopoietic cell lineage, are transcriptionally
repressed remain to be elucidated.
TIF1b (also called KAP1 or TRIM28) is a transcriptional
corepressor that associateswithhundredsofKruppel-associ-
ated boxdomain-zinc finger proteins (KRAB-ZFPs) that bind
DNA in a sequence-specific fashion. TIF1b acts as a scaffold
for a multimolecular complex that silences transcription
through the formation of heterochromatin by recruitingStem Cellthe histone methyltransferase SETDB1, heterochromatin
protein 1 (HP1), or the NuRD-histone deacetylase complex
(Nielsen et al., 1999; Schultz et al., 2001, 2002). The
KRAB/KAP1 system plays a critical role in the control of
endogenous retroviruses during development (Rowe et al.,
2010, 2013) but also regulates multiple aspects of mamma-
lian physiology. In hematopoiesis, it functions in erythro-
poiesis and in the prevention of autoinflammatory T cell
development (Chikuma et al., 2012; Barde et al., 2013).
In this study, we demonstrate an essential role for the
TIF1b/HP1 system in the maintenance of HSCs and impli-
cate this system in the establishment of transcriptional
signature of HSCs by keeping nonhematopoietic genes
transcriptionally silent.RESULTS AND DISCUSSION
Deletion ofTif1b Severely Compromises HSC Function
in the Fetal Liver
Tif1b-deficient mice show early developmental defects and
die by embryonic day 7.5 (E7.5) (Cammas et al., 2000). To
delineate function of TIF1b in HSCs, we conditionally
deleted Tif1b by crossing Tif1bfl/fl mice with Tie2-Cremice,
which specifically express Cre in hematopoietic and endo-
thelial cells (Tie2-Cre;Tif1bfl/fl). We confirmed efficientReports j Vol. 2 j 145–152 j February 11, 2014 j ª2014 The Authors 145
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B Figure 1. Tie2-Cre;Tif1bfl/fl Embryos Die
at Midgestation
(A) Appearance of Tie2-Cre (Tif1b+/+)
and Tie2-Cre;Tif1bfl/fl (Tif1bD/D) embryos at
E13.5.
(B) Absolute numbers of whole fetal liver
cells, c-KIT+ progenitors, and TER119+
erythroblasts at E13.5. The data are shown
as mean ± SEM (Tie2-Cre, n = 16; Tie2-Cre;
Tif1bfl/fl, n = 17).
(C) Absolute numbers of erythroid cells at
different stages defined by CD71 and
TER119 expression in fetal livers at E13.5.
The data are shown as mean ± SEM (Tie2-
Cre, n = 16; Tie2-Cre;Tif1bfl/fl, n = 17).
(D) Morphology of Tif1b+/+ and Tif1bD/D
fetal liver hematopoietic cells from
E13.5 embryos stained with May-Gru¨nwald-
Giemsa solution.
(E) Absolute cell numbers of LSK and
CD150+LSK cells in the fetal liver at E13.5.
The data are shown as mean ± SEM (Tie2-
Cre, n = 23; Tie2-Cre;Tif1bfl/fl, n = 21).
(F) Growth of Tif1b+/+ and Tif1bD/D LSK cells
from E13.5 fetal livers in liquid culture in
the presence of 50 ng/ml of SCF and TPO.
The data are shown as mean ± SEM for
triplicate cultures.
(G) Colony-forming assays with Tif1b+/+ and
Tif1bD/D fetal liver cells. Left panel shows
the absolute number of colonies with the
indicated size per 20,000 fetal liver cells.
The data are shown as mean ± SEM for
triplicate cultures. Right panel shows the
proportion of colony types defined by the
composition of colony-forming cells (n,
neutrophil; m, macrophage; E, erythroblast;
M, megakaryocyte).
(H) Competitive repopulating assays. A
total of 2 3 105 Tif1b+/+ and Tif1bD/D fetal
liver cells from E13.5 embryos (CD45.2)
mixed with the same number of competitor
BM cells (CD45.1) were transplanted into
CD45.1 recipients. Chimerism of donor-
derived CD45.2+ cells in the PB is shown in
the left panel. Donor chimerism in the BM
LSK cells at 12 weeks posttransplantation is
shown in the right panel. The data are
shown as mean ± SEM (n = 6). *p < 0.05;
**p < 0.005; ***p < 0.0005.
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Regulation of HSC Signature via TIF1bdeletion of Tif1b in fetal liver lineage-marker (Lin)c-KIT+
hematopoietic progenitor cells from Tie2-Cre;Tif1b mice
by western blot and immunocytochemical analyses in
Linc-KIT+SCA-1+ (LSK) hematopoietic stem and progeni-
tor cells (HSPCs) (Figures S1A and S1B available online).
Tie2-Cre;Tif1bfl/fl embryos were recovered at nearly the ex-146 Stem Cell Reports j Vol. 2 j 145–152 j February 11, 2014 j ª2014 The Apected Mendelian ratio at E13.5, but about 28% (58 out
of 207 Tie2-Cre;Tif1bfl/fl embryos) were already dead and
no mutant embryos were born alive (data not shown).
Tie2-Cre;Tif1bfl/fl embryos were pale and their fetal livers
were significantly smaller than those of the littermate
controls (Figures 1A and 1B). Flow cytometric analysesuthors
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Regulation of HSC Signature via TIF1bdemonstrated a significant reduction in TER119+ erythro-
blasts in Tie2-Cre;Tif1bfl/fl fetal livers (Figure 1B). Detailed
analysis revealed a block in differentiation of Tif1bD/D
erythroblasts from CD71+TER119 early erythroblasts
to CD71+TER119+ erythroblasts (Figure S1C), resulting
in a drastic reduction in the numbers of Tif1bD/D
CD71+TER119+ and CD71TER119+ mature erythroblasts
(Figure 1C). Indeed, Tif1bD/D erythroblasts were mostly
proerythroblasts, while the control erythroblasts were
at various differentiation stages from proerythroblasts to
mature erythroblasts (Figure 1D). These data are consistent
with the recent reports on the impact of deletionofTif1bon
erythropoiesis (Barde et al., 2013), suggesting that severe
anemia due to impaired erythroid differentiation could ac-
count for embryonic lethality of Tie2-Cre;Tif1bfl/fl embryos.
Of note, CD150+LSK HSCs and LSK HSPCs were also
significantly reduced in Tie2-Cre;Tif1bfl/fl fetal livers at
E13.5 compared to the controls (Figures 1E and S1D).
Tif1bf/D LSK cells proliferated poorly in liquid culture
compared to the control cells (Figure 1F). In colony-form-
ing assays, Tif1bD/D LSK cells gave rise to significantly fewer
colonies than control cells and failed to form colonies
larger than 2 mm in diameter. Most of the colonies
generated from Tif1bD/D LSK cells consisted of only neu-
trophils and macrophages with very few megakaryocytes
but completely lacked erythroblasts (Figure 1G). We next
performed competitive reconstitution assays. Not surpris-
ingly, Tif1bD/D cells did not contribute to hematopoiesis
in the recipient mice in either the peripheral blood (PB)
or the bone marrow (BM) (Figure 1H). Further examina-
tion revealed that Tif1b+/D cells also performed poorly in
competitive reconstitution assays, suggesting a haploin-
sufficient effect with Tif1b heterozygotes (data not shown).
Moreover, Tif1bD/D cells failed to extend the survival of
lethally irradiated recipient mice (Figure S1E). These results
indicate that loss of TIF1b severely impairs the capacity of
HSCs to repopulate hematopoiesis in vivo.
Deletion of Tif1b Causes BM Failure Accompanied by
Depletion of HSCs
To evaluate the role of TIF1b in adult BMhematopoiesis, we
next analyzed Cre-ERT;Tif1bfl/fl mice. To exclude any
influences of deletion of Tif1b on the BM microenviron-
ment, we first transplanted BM cells from Cre-ERT control
and Cre-ERT;Tif1bfl/fl mice without competitor cells into
lethally irradiated wild-type recipient mice. After confirm-
ing engraftment, we deleted Tif1b by inducing nuclear
translocation of Cre with intraperitoneal injection of
tamoxifen at 8 weeks after transplantation. Deletion of
Tif1b was very efficient, with deletion efficiency in BM
Linc-KIT+ progenitor cells at 92.6% by genomic quantita-
tive PCR (data not shown). As indicated by mild reduction
in BM cellularity and mild cytopenia in Cre-ERT controlStem Cellmice, tamoxifen had some toxic effects on hematopoiesis
at the early time points postinjection (Figures 2B and
S2A). Deletion of Tif1b, however, induced progressive
hypoplasia of the BM and the spleen (Figures 2A and 2B)
and caused obvious cytopenia in the PB (Figure S2A).
Although residual Ly5.1+ host cells gradually overtook
Tif1bD/D cells and eventually restored the blood cell counts
in the PB (Figures S2A and S2B), about 70% of the trans-
planted mice died of BM failure within 40 days of tamox-
ifen injection (Figure 2C).
Of interest, the number of Tif1bD/D HSCs increased tran-
siently at 2 weeks postdeletion and then dramatically
decreased by 4 weeks postdeletion (Figure 2D), suggesting
enhanced cycling of HSCs. Indeed, 66% of the Tif1bD/D
HSCs had exited the quiescent G0 stage and a significant
portion of them were actively cycling compared to the
control HSCs (Figures 2E and S2C). A significant number
of Tif1bD/D HSPCs egressed from BM to the periphery as
evident from a drastic increase in LSK HSPCs and Linc-
KIT+ progenitors in the PB (Figure 2F), suggesting a BM
niche-interaction defect in Tif1bD/D HSPCs. In addition,
Tif1bD/D HSCs underwent massive apoptosis (Figure 2G).
Among the myeloid progenitors, the numbers of Tif1bD/D
granulocyte-macrophage progenitors (GMPs) and mega-
karyocyte-erythroid progenitors (MEPs) were also signifi-
cantly reduced at 4 weeks postdeletion (Figure S2D).
Furthermore, Tif1bD/D LSK cells proliferated poorly in cul-
ture (Figure S2E). We next examined the long-term recon-
stitution capacity of Tif1b-deficient BM cells. To this end,
control and Cre-ERT;Tif1bfl/fl BM cells were transplanted
along with the same number of BM competitor cells into
lethally irradiated wild-type recipients. Upon deletion of
Tif1b at 8 weeks after transplantation, donor cells were
rapidly outcompeted by the competitor cells and quickly
depleted from both the PB and the BM (Figure 2H).
In contrast to its role in erythropoiesis (Barde et al.,
2013), the role of TIF1b has never been tested in myeloid
cells. We therefore analyzed lysozyme-Cre;Tif1bfl/fl mice, in
which Cre is active only in myeloid cells at the maturation
stages beyond GMPs. Surprisingly enough, lysozyme-Cre;
Tif1bfl/fl mice showed no obvious defects in myeloid differ-
entiation. The hematological data, including the PB cell
counts and the lineage composition and the number of
BM cells, myeloid progenitor cells and HSCs were almost
normal (Figure S3). These findings underline the lineage-
specific functions of TIF1b in hematopoiesis.
Loss of HSC Signature in the Absence of TIF1b
To elucidate the changes in gene expression responsible for
impaired HSC function in the absence of TIF1b, we per-
formed microarray analysis using LSK cells at 2 weeks post-
deletion of Tif1b (Figure 3A). The analysis revealed that 541
genes were upregulated more than 2-fold and 486 genesReports j Vol. 2 j 145–152 j February 11, 2014 j ª2014 The Authors 147
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Figure 2. Deletion of Tif1b Leads to
Rapid BM Failure
(A) Hematoxylin and eosin staining of BM
sections from Cre-ERT (Tif1b+/+) and Cre-
ERT;Tif1bfl/fl (Tif1bD/D) mice at 2 and
4 weeks postdeletion of Tif1b. BM cells from
8-week-old Cre-ERT and Cre-ERT;Tif1bfl/fl
mice were transplanted into lethally irradi-
ated recipient mice without competitor
cells. At 8 weeks after transplantation,
recipient mice were injected with tamoxifen
for 5 consecutive days.
(B) Absolute numbers of total BM and
spleen cells at the indicated time points
postdeletion of Tif1b (2 weeks [2w], n = 8;
4 weeks [4w], n = 8–10).
(C) Survival curve of the recipient mice
repopulated with BM cells from Cre-ERT and
Cre-ERT;Tif1bfl/fl mice after deletion of Tif1b
(n = 12).
(D) Absolute numbers of total Tif1b+/+ and
Tif1bD/D CD34LSK HSCs in the BM at the
indicated time points after deletion of Tif1b
(n = 8).
(E) Cell-cycle status of Tif1b+/+ and Tif1bD/D
CD34LSK HSCs determined by incorpora-
tion of Pyronin Y at 2 weeks after the first
injection of tamoxifen. Representative flow
cytometric profiles are depicted (upper
panel) and the proportion of pyronin
Y-negative cells in CD34LSK HSCs is shown
as the mean ± SEM (n = 4) (lower panel).
(F) Detection of Tif1b+/+ and Tif1bD/D HSPCs
in the PB at 2 weeks after the first injection
of tamoxifen. Representative flow cyto-
metric profiles of LSK cells from CreERT and
CreERT;Tif1bfl/fl mice are depicted (upper
panel) and the proportions of Linc-Kit+ and
LSK cells in total mononuclear cells is shown
as the mean ± SEM (n = 4) (lower panel).
(G) Apoptosis in BM CD45.2+LSK cells from
recipient mice detected with Annexin V and
7-aminoactinomycin D (7-AAD) by flow cy-
tometry at the indicated time points after
deletion of Tif1b. The data are shown as
mean ± SEM (n = 4).
(H) Competitive reconstitution assays. BM cells from 8-week-old CreERT and CreERT;Tif1bfl/fl mice were transplanted into lethally irradiated
recipient mice with the same number of competitor BM cells (13 106 cells). At 8 weeks posttransplantation, recipient mice were injected
with tamoxifen for 5 consecutive days. The chimerism of CD45.2+ donor-derived cells in the PB of recipient mice is shown as % of chimerism
values prior to treatment with tamoxifen (left panel). Donor chimerism in the BM LSK and CD34LSK cells at 12 weeks after injection of
tamoxifen is also shown (right panel). The data are shown as mean ± SEM (n = 6). *p < 0.05; **p < 0.005; ***p < 0.0005.
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Regulation of HSC Signature via TIF1bwere downregulatedmore than 2-fold compared to control
cells reproducibly in two independent experiments. We
first performed gene set enrichment analysis (GSEA)
to see if there was a fundamental loss of stem-cell-like
gene expression in Tif1bD/D HSCs. Using the microarray148 Stem Cell Reports j Vol. 2 j 145–152 j February 11, 2014 j ª2014 The Adata taken from various hematopoietic compartments
(CD34LSKHSCs, CD34+LSKMPPs, Linc-KIT+ committed
progenitors, and Lin+ differentiated cells), we found that a
gene signature unique to CD34LSK HSCs was actually en-
riched in Tif1bD/DLSKs (Figure 3B). This suggests that a lossuthors
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Figure 3. Derepression of Nonhemato-
poietic Genes in Tif1b-Deficient LSK Cells
(A) Heatmap of the expression of genes that
were upregulated (541 probe sets, upper
panel) or downregulated (486 probe sets,
lower panel) more than 2-fold in Tif1b-
deficient BM LSK cells in the microarray
analysis.
(B) GSEA of the gene set specific to
CD34LSK HSCs in Tif1bD/D LSK cells. Using
the microarray data from CD34LSK HSCs,
CD34+LSK MPPs, Linc-KIT+ committed
progenitors, and Lin+ differentiated cells,
HSC-specific gene sets were selected and
applied to GSEA.
(C) Upregulated genes in (A) were divided
into two groups according to their expres-
sion levels in Tif1bD/D LSK cells compared to
that in control LSK cells. One group consist
of probe sets that were expressed in
the control LSK cells and their expression
levels were enhanced upon deletion of Tif1b
(‘‘enhanced’’ genes). The other group in-
cludes probe sets that were not expressed in
the control LSK cells but became activated
in Tif1b-deficient LSK cells (‘‘activated’’
genes). Bar graph shows proportions of
these groups.
(D) Schematic representation of expression
profiles of ‘‘Activated’’ genes in BM Tif1b-
deficient LSK cells in (A) in various
hematopoietic cell fractions, including
CD34LSK HSCs, CD34+LSK MPPs, Linc-KIT+
committed progenitors, and Lin+ differen-
tiated cells. Expressed genes are depicted
as a red bar.
(E) Proportions of probe sets in (D) that
were not expressed in any of the hemato-
poietic cell fractions (Not expressed) and those expressed in at least one of the hematopoietic cell fractions including CD34LSK HSCs,
CD34+LSK MPPs, Linc-KIT+ committed progenitors and Lin+ differentiated cells (Expressed).
(F) Heatmap of the expression of miRNAs that were upregulated (15 miRs) or downregulated (80 miRs) more than 2-fold in Tif1b-deficient
BM LSK cells in the microarray analysis.
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observed in Tif1b-deficient mice.
We next focused on the genes derepressed in the absence
of TIF1b. Among genes derepressed, a significant portion of
genes became transcriptionally detectable from undetect-
able levels (‘‘activated’’) in Tif1bD/D LSK cells (Figure 3C).
We then compared the expression profiles of the ‘‘acti-
vated’’ genes in Tif1bD/D BM LSK cells to various hema-
topoietic compartments, including CD34LSK HSCs,
CD34+LSK MPPs, Linc-KIT+ committed progenitors, and
Lin+ differentiated cells (Figure 3D). To our surprise, the
majority of ‘‘activated’’ gene transcripts were not detected
in any of these hematopoietic compartments (Figure 3E).Stem CellThese results suggest that TIF1b is required for the gene
silencing of nonhematopoietic genes in HSPCs.
Among gene sets positively enriched (derepressed) in
Tif1bD/D LSK cells,many genes sets were related to signaling
pathways mediated by cell surface receptors or adhesion
molecules (e.g., integrin signaling pathway, gap junction,
and focal adhesion; see Table S1) and upregulation of
such genes was confirmed by quantitative RT-PCR (Fig-
ure S4A). These results indicate deregulated expression
of nonhematopoietic adhesion molecules in Tif1bD/D
HSCs, which might result in impaired niche interaction
in Tif1bD/D HSCs and enhanced egression of HSCs from
the BM to the periphery.Reports j Vol. 2 j 145–152 j February 11, 2014 j ª2014 The Authors 149
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Figure 4. HP1 Depletion Compromises
the Proliferation of HSCs
(A) Western blot analysis of Linc-Kit+ fetal
liver cells from Tie2-Cre and Tie2-Cre;Tif1bfl/fl
embryos. Levels of HP1 proteins were
normalized to the amount of b-tubulin. The
relative levels of HP1 proteins are indicated
in the right panel. The data are shown as
mean ± SEM (n = 3).
(B) Immunostaining of HP1a and H3K9me3
in LSK cells from Tie2-Cre and Tie2-Cre;
Tif1bfl/fl fetal livers at E13.5. Cells were
counterstained with DAPI. Representative
three individual cell images are depicted.
Numbers of chromocenters per cell are
shown in the bottom panel. In total, 100
cells were counted for the scoring of the
chromocenters.
(C) Growth of CD34KSL HSCs upon deple-
tion of Hp1 genes in vitro. HSCs were
transduced with lentiviruses generating
shRNAs against Luciferase (Luc), Hp1a,
Hp1b, and Hp1g and then allowed to prolif-
erate in the presence of 100ng/ml of SCF and
TPO for 14 days. The transduction efficiency
was around 75% in most experiments as
judged from the GFP expression. The data are
shown as mean ± SEM for triplicate cultures.
(D) Analysis of CD34KSL HSC cultures
depleted of Hp1 genes in (C) at day 14. The
proportion of LSK cells in GFP+ cells is shown.
The data are shown as mean ± SEM (n = 3).
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Regulation of HSC Signature via TIF1bBarde et al. (2013) have recently reported that deletion of
Tif1b results in compromised erythropoiesis due to failure
in the induction of mitophagy-related genes. They found
that the TIF1b together with KRAB-ZNF represses the tran-
scription of microRNAs (miRNAs) targeting mitophagy
transcripts to inducemitophagy during the terminal differ-
entiation of erythroblasts. Profiling of miRNAs in Tif1bD/D
LSK cells revealed upregulation of 15 miRNA greater than
2-fold compared to control cells (Figure 3F). However,
none of the mitophagy-related miRNAs described by Barde
et al. were upregulated inTif1bD/D LSK cells. In addition, the
expression levels of mitophagy-related genes were not
significantly altered in Tif1bD/D LSK cells (data not shown).
Together, these findings highlight the cell-type-specific as
well as differentiation stage-specific functions of TIF1b in
hematopoiesis. Nonetheless, it should be noted that some
of the upregulated miRNAs potentially target genes down-
regulated in Tif1bD/D LSK cells, implying involvement of
derepressed miRNAs in altered gene expression in Tif1bD/D
LSK cells (data not shown).
TIF1b has been characterized to suppress activation of
p53 (Tian et al., 2009). Indeed, p53 target genes, such as150 Stem Cell Reports j Vol. 2 j 145–152 j February 11, 2014 j ª2014 The Aproapoptotic genes Bax, Noxa, and p21, were upregulated
in fetal Tif1bD/D LSK cells (Figure S4B). In order to evaluate
the contribution of p53, we transplanted Cre-ERT;Tif1bfl/fl
CD34LSK HSCs transduced with the E6 oncoprotein, a
potent p53 inhibitor, into lethally irradiated recipients.
E6, however, did not have any gross effects on the repopu-
lating capacity of Tif1bD/D HSCs (Figure S4C), suggesting
that the activated p53 response is not the causative event
in the hematopoietic failure induced by absence of TIF1b.
Reduction in HP1 Proteins in the Absence of TIF1b
TIF1b physically interacts with all of the HP1 proteins
(HP1a, HP1b, and HP1g; Nielsen et al., 1999; Cammas
et al., 2002, 2007) and recruits them in order to establish
deep silencing of their target genes (Nielsen et al., 1999;
Schultz et al., 2002). Notably, levels of all three members
of the HP1 family proteins were reduced approximately
2-fold in fetal liverTif1bD/D Linc-KIT+ progenitor cells (Fig-
ure 4A), though their transcription levels were not signifi-
cantly changed (data not shown). In accordance with this
finding, immunostaining of fetal liver LSK cells revealed
a reduction in numbers of chromocenters, a structuraluthors
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Regulation of HSC Signature via TIF1bcomponent of heterochromatin where HP1a accumulates,
in the absence of TIF1b (Figure 4B). These results support
the notion that TIF1b functions as a scaffold that stabilizes
HP1 proteins. The level of HP1a protein was significantly
reduced also in NIH 3T3 cells depleted of TIF1b. However,
inhibition of proteasome activity by MG132 in NIH cells
failed to stabilize HP1a upon knockdown of Tif1b, leaving
themolecularmechanism throughwhich theHP1 proteins
are destabilized in the absence of TIF1b still obscure (data
not shown). HP1 proteins are recruited to their target loci
via physical interactionwith TIF1b as well as through direct
binding to trimethylated H3K9 to form transcriptionally
inactive heterochromatin (Nestorov et al., 2013). The levels
of global histone modifications, including H3K9me1/2/3,
did not significantly change in Tif1bD/D Linc-KIT+ progen-
itor cells (Figure S4D). These findings further suggest that
TIF1b regulates HP1 function not only by tethering them
to their targets but also by securing their posttranslational
stability. In order to test whether the reduction in levels
of HP1 proteins is involved in the impaired function of
Tif1bD/D HSCs, we knocked down the Hp1 genes in HSCs
using small hairpin RNAs (shRNAs) (Figure S4E). Growth
of HSCs was significantly impaired upon depletion of
Hp1a and Hp1g, but not Hp1b (Figure 4C). The proportion
of LSK HSPCs in GFP+ transduced cells was also signifi-
cantly decreased upon depletion of Hp1a and Hp1g, but
not Hp1b, at day 14 of culture (Figure 4D). These results
suggest that reduced levels of HP1 proteins play a role
in determining the phenotypes of Tif1b-deficient HSCs.
Together, our findings highlight the TIF1b-HP1 system as
critical transcriptional machinery that keeps nonhemato-
poietic genes repressed in HSCs, thereby maintaining the
transcriptional signature specific to HSCs.
TIF1b has been reported to repress the expression of
endogenous retrotransposons in embryonic stem cells via
the histone methyltransferase ESET/SETDB1 and subse-
quent H3K9 trimethylation (Matsui et al., 2010; Rowe
et al., 2010). However, we did not observe any significant
derepression of endogenous retrotransposons in Tif1bD/D
LSK cells (data not shown), indicating that different
silencing machineries are operating in embryonic stem
cells and somatic stem cells. Of interest, the phenotypes
of Tif1bD/D HSCs are similar to those of HSCs deficient for
MI-2b, a component of the NuRDhistone deacetylase com-
plex, which directly interacts with TIF1b (Schultz et al.,
2001; Yoshida et al., 2008). TIF1b may thus collaborate
with the NuRD complex, in addition to HP1 proteins,
and stabilize these repressor molecules critical for the tran-
scriptional repression of nonhematopoietic genes in HSCs.
The epigenetic regulation of transcription is crucial for
the maintenance of cell-type-specific signatures (Sashida
and Iwama, 2012). In the point of view of transcriptional
regulation, multipotency of stem cells can be defined asStem Cellan ability of stem cells to express a set of genes required
for differentiation and cell-type-specific function upon
cell differentiation. The PcG proteins maintain this ‘‘tran-
scriptional competence’’ by transiently silencing genes
that will be activated during differentiation of stem cells
(Sauvageau and Sauvageau, 2010). In contrast, our findings
in this study indicate that the TIF1b-HP1 system, which
collaborates with H3K9me3 and DNA methylation (Rowe
et al., 2013), is involved in establishing a more stable
silencing state of genes that would never be activated in a
given cell lineage. However, the precise mechanisms by
which the epigenetic switching between the reversible
PcG-mediated system and the TIF1b-HP1 system that we
propose here remain to be elucidated. Understanding
how these different repressive systems work would prove
invaluable to our understanding of the epigenetic regula-
tion of stem cells.EXPERIMENTAL PROCEDURES
Details regarding experimental procedures are available in Supple-
mental Experimental Procedures.
ACCESSION NUMBERS
Microarray data have been deposited in the NCBI Gene Expression
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